LEV Medical

Revolutionizing Targeted Temperature Management & Resuscitation Technology At TTM Inc., we are developing next-generation Targeted Temperature Management (TTM) and Resuscitation Technologies to transform critical care for cardiac arrest, stroke, neonatal hypoxic encephalopathy, cerebral edema, and acute respiratory distress syndrome (ARDS). A Breakthrough in Therapeutic Hypothermia Current hypothermia devices are ineffective, complex, and underutilized. Our patented TTMS, developed by Sergei Shushunov, MD, introduces a novel, non-invasive method to induce, maintain, and reverse hypothermia by delivering Hyper-Cold™ air through a ventilator — expanding access to pre-hospital settings like ambulances, air transport, and military field hospitals. Key Advantages: ✅ Rapid, precise cooling ✅ Seamless ventilator integration ✅ Portable, user-friendly design Next-Generation Resuscitation Ventilator CPR outcomes have plateaued — it's time for a paradigm shift. Our by-phasic resuscitation ventilator is synchronized with chest compressions to augment blood flow and improve survival rates during sudden cardiac arrest. Key Features: 🔹 Dual-chamber system for consistent compressions 🔹 Venous return enhancement 🔹 Intelligent synchronization with CPR efforts We believe incremental improvements won't be enough—it's time for a fundamental change in resuscitation technology. We're seeking partners and investors to conduct proof-of-concept laboratory studies and bring these life-saving innovations to market. Visit hypothermiatherapy.com to learn more. Let's redefine critical care — together. 🚀

• Employees 1
• Founded 2014